Enasidenib Mesylate

CHEMBL3989931 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

569.5 g/mol

LogP

—

Phase

4

The mesylate salt form of enasidenib, this medication blocks a mutated enzyme to stop the growth of certain leukemia cells. The mesylate form helps with formulation and absorption of the active compound.

الوزن الجزيئي

569,5000 g/mol

TPSA

171,00 Å²

المجالات العلاجية

Pancreatic Cancer Lymphoma Breast Cancer Prostate Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1.CS(=O)(=O)O

InChI

InChI=1S/C19H17F6N7O.CH4O3S/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25;1-5(2,3)4/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32);1H3,(H,2,3,4)

Molecular Formula

C20H21F6N7O4S

HBD / HBA

4 / 17

الروابط القابلة للدوران

6

الذرات الثقيلة

38

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

The mesylate salt form of enasidenib, this medication blocks a mutated enzyme to stop the growth of certain leukemia cells. The mesylate form helps with formulation and absorption of the active compound.

Yes, Enasidenib Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989931. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 90480031. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Enasidenib Mesylate على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C20H21F6N7O4S
المرادفات: 1

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.